Intron Biotechnology Inc. | Cash Flow
Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Net Income before Extraordinaries
354
21
1,558
610
8,348
Depreciation, Depletion & Amortization
1,035
811
972
1,253
1,263
Other Funds
1,134
1,178
719
901
2,800
Funds from Operations
1,159
2,491
3,830
768
195
Changes in Working Capital
1,351
1,852
2,131
2,731
2,438
Net Operating Cash Flow
192
639
1,699
1,963
2,243
Capital Expenditures
2,302
1,859
6,300
4,724
4,460
Sale of Fixed Assets & Businesses
7
-
-
-
57
Purchase/Sale of Investments
560
7,013
2,536
5,272
791
Net Investing Cash Flow
2,855
8,872
3,714
10,231
5,125
Issuance/Reduction of Debt, Net
2,901
11,296
3,062
571
1,597
Net Financing Cash Flow
4,028
11,982
3,781
21,961
4,397
Net Change in Cash
981
3,749
1,772
9,847
3,105
Free Cash Flow
691
619
2,333
3,752
3,217
Net Assets from Acquisitions
-
-
-
225
-
Other Sources
69
-
50
65
75
Change in Capital Stock
6
491
-
21,631
-
Exchange Rate Effect
-
-
5
80
135
About Intron Biotechnology
View Profile
